Atlas Trials

Effect of Methamphetamine on Residual Latent HIV Disease Study

Clinical trial NCT03825536 · COMPLETED

Trial details

NCT number
NCT03825536
Sponsor
University of California, San Francisco
Status
COMPLETED
Phase
Phase 4
Study type
INTERVENTIONAL
HIV-1-infectionMethamphetamine-dependence
Start date
2021-01-01
Primary completion
2023-01-11
Enrollment
14

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.